Skip to main
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. reported a significant year-over-year gross margin increase of approximately 80 basis points, reaching 79.8% for the second quarter of 2025, which indicates improved operational efficiency. The company achieved a revenue growth of around 23% year-over-year, totaling $46.4 million, driven by a notable increase in surgeon interactions and productivity from sales representatives. Furthermore, the upward revision of the 2025 revenue estimate to $196.5 million reflects the strong performance in Q2 and enhanced sales productivity, underscoring a positive trajectory for the company’s financial performance.

Bears say

The analysis indicates a negative outlook for SI-BONE Inc. primarily due to persistent pricing and procedural challenges within the global spine market, which have resulted in diminished growth rates in the low-single digits. Furthermore, the potential for payors to favor reimbursement for competitive products poses a significant risk to SI-BONE’s market share in the sacroiliac joint fusion market, which could detrimentally impact the company's revenue. Additionally, SI-BONE's EV/sales/growth metric of 0.19x significantly lags behind the median of 0.34x among its small to mid-cap growth peers, underscoring potential concerns regarding valuation and future growth prospects.

SI-BONE Inc (SIBN) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Buy based on their latest research and market trends.

According to 6 analysts, SI-BONE Inc (SIBN) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.